Small molecule inhibitors of HCV replication from Pomegranate

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Reddy, B Uma ^a   Mullick, Ranajoy ^a   Kumar, Anuj ^a   Sudha, Govindarajan ^a   Srinivasan, Narayanaswamy ^a   Das, Saumitra ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ELLAGIC ACID; MOLECULAR LIBRARY; NS3 PROTEIN, HEPATITIS C VIRUS; PROTEIN BINDING; PUNICALAGIN; PUNICALIN; TANNIN; VIRUS PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEPACIVIRUS; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST PATHOGEN INTERACTION; HUMAN; LYTHRACEAE; MASS SPECTROMETRY; METABOLISM; MOLECULAR LIBRARY; PHARMACOLOGY; PHYTOTHERAPY; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELLAGIC ACID; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROLYZABLE TANNINS; MASS SPECTROMETRY; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHYTOTHERAPY; PROTEIN BINDING; PUNICACEAE; SMALL MOLECULE LIBRARIES; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84903202749     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05411     Document Type: Article

References (60)

1. Boyer, N. & Marcellin, P. Pathogenesis, diagnosis and management of hepatitis C. J. Hepatol. 32, 98-112 (2000). (Pubitemid 30123628)
2. Horner, S. M. & Gale, M. Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat. Med. 19, 879-888 (2013).
3. Guedj, J., Dahari, H., Pohl, R. T., Ferenci, P. & Perelson, A. S. Understanding silibinin's modes of action against HCV using viral kinetic modeling. J. Hepatol. 56, 1019-1024 (2012).
4. Trecul, A., Morceau, F., Dicato, M. & Diederich, M. Dietary compounds as potent inhibitors of signal transducers and activators of transcription (STAT) 3 regulatory network. Genes Nutr. 7, 111-125 (2012).
5. Nahmias, Y. et al. Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology 47, 1437-1445 (2008). (Pubitemid 351702727)
6. Takeshita, M. et al. Proanthocyanidin from blueberry leaves suppresses expressionofsubgenomic hepatitisC virusRNA.J.Biol. Chem. 284, 21165-21176 (2009).
7. Kim, K. et al. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett. 584, 707-712 (2010).
8. Anggakusuma. et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. (2013).
9. Calland, N. et al. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology 55, 720-729 (2012).
10. Lin, Y. T. et al. Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation. PLoS One 8, e54466 (2013).
11. Gonzalez, O. et al. The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology 50, 1756-1764 (2009).
12. Bachmetov, L. et al. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J. Viral Hepat. 19, e81-e88 (2012).
13. Jurenka, J. S. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern. Med. Rev. 13, 128-144 (2008).
14. Adams, L. S., Zhang, Y., Seeram, N. P., Heber, D. & Chen, S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev. Res. (Phila) 3, 108-113 (2010).
15. Neurath, A. R., Strick, N., Li, Y. Y. & Debnath, A. K. Punica granatum (Pomegrante) juice provides an HIV-1 entry inhibitor and candidate topical microbicide. BMC Infect. Dis. 4, 41 (2004).
16. Nonaka, G. et al. Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells. J. Nat. Prod. 53, 587-595 (1990). (Pubitemid 20311254)
17. Sundararajan, A. et al. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Res. 88, 1-9 (2010).
18. Yang, Y., Xiu, J., Zhang, L., Qin, C. & Liu, J. Antiviral activity of punicalagin toward human enterovirus 71 in vitro and in vivo. Phytomedicine 20, 67-70 (2012).
19. Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M. & Kader, A. A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48, 4581-4589 (2000).
20. Malik, A.etal. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA. 102, 14813-14818 (2005). (Pubitemid 41457138)
21. Thresiamma, K. C. & Kuttan, R. Inhibition of liver fibrosis by ellagic acid. Indian J. Physiol. Pharmacol. 40, 363-366 (1996). (Pubitemid 26420820)
22. Di Marco, S. et al. Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes. J. Biol. Chem. 275, 7152-7157 (2000). (Pubitemid 30146264)
23. Lin, C. (2006). HCV NS3-4A serine protease. In: Tan, S. L., editor. Hepatitis C viruses: Genomes and Molecular Biology. Norfolk (UK): Horizon Bioscience; 2006. Chapter 6. http://www.ncbi.nlm.nih.gov/books/NBK1623/.
24. Romano, K. P. et al. The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors. PLoS Pathog. 8, e1002832 (2012).
25. Transue, T. R., Krahn, J. M., Gabel, S. A., DeRose, E. F. & London, R. E. X-ray and NMR characterization of covalent complexes of trypsin, borate and alcohols. Biochemistry. 43, 2829-2839 (2004). (Pubitemid 38327814)
26. Murzin, A. G., Brenner, S. E., Hubbard, T. & Chothia, C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 247, 536-540 (1995).
27. Zhang, Y. & Skolnick, J. TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res. 33, 2302-2309 (2005). (Pubitemid 41439897)
28. Frese, M. et al. Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha. J. Gen. Virol. 84, 1253-1259 (2003). (Pubitemid 36592618)
29. Lanford, R. E., Sureau, C., Jacob, J. R., White, R. & Fuerst, T. R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202, 606-614 (1994). (Pubitemid 24254873)
30. Craggs, J. K., Ball, J. K., Thomson, B. J., Irving, W. L. & Grabowska, A. M. Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA. J. Virol. Methods 94, 111-120 (2001). (Pubitemid 32411483)
31. Kitazato, K., Wang, Y. & Kobayashi, N. Viral infectious disease and natural products with antiviral activity. Drug Discov. Ther. 1, 14-22 (2007).
32. Raney, K. D., Sharma, S. D., Moustafa, I. M. & Cameron, C. E. Hepatitis C virus non structural protein 3 (HCV NS3): a multifunctional antiviral target. J. Biol. Chem. 285, 22725-22731 (2010).
33. Romano, K. P. et al. Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease. J. Virol. 85, 6106-6116 (2011).
34. Haslam, E. Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J. Nat. Prod. 59, 205-215 (1996). (Pubitemid 27079849)
35. Li, X., Zhang, W., Qiao, X. & Xu, X. Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method. Bioorg. Med. Chem. 15, 220-226 (2007). (Pubitemid 44738583)
36. Waris, G. & Siddiqui, A. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J. Virol. 79, 9725-9734 (2005). (Pubitemid 41022315)
37. Leng, J., Han, C., Demetris, A. J., Michalopoulos, G. K. & Wu, T. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through AKT activation: evidence for AKT inhibition in celecoxib-induced apoptosis. Hepatology 38, 756-768 (2003). (Pubitemid 37052162)
38. Cooray, S. The pivotal role of phosphotidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 85, 1065-1076 (2004). (Pubitemid 38659771)
39. Shukla, M., Gupta, K., Rasheed, Z., Khan, K. A. & Haqqi, T. M. Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro. J. Inflamm. (Lond) 5, 9 (2008).
40. Lansky, E. P. et al. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest. New Drugs 23, 11-20 (2005). (Pubitemid 39516965)
41. Vanella, L. et al. Apoptotic markers in a prostate cancer cell line: effect of ellagic acid. Oncol. Rep. 30, 2804-2810 (2013).
42. Edderkaoui, M. et al. Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J. Gastroenterol. 14, 3672-3680 (2008).
43. Mishra, S. & Vinayak, M. Anti-carcinogenic action of ellagic acid mediated via modulationof oxidative stress regulated genes inDalton lymphoma bearing mice. Leuk. Lymphoma 52, 2155-2161 (2011).
44. Cerda, B., LIorach, R., Ceron, J. J., Espin, J. C. & Tomas-Barberan, F. A. Evaluation of the bioavailability and metabolism in the rat of punicalagin, anantioxidant polyphenol from pomegranate juice. Eur. J. Nutr. 42, 18-28 (2003). (Pubitemid 36286302)
45. Cerda, B., Ceron, J. J., Tomas-Barberan, F. A. & Espin, J. C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J. Agric. Food Chem. 51, 3493-3501 (2003).
46. Kato, T. et al. Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1, 2334-2339 (2006).
47. Yi, M., Ma, Y., Yates, J. & Lemon, S. M. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious inter genotypic chimeric hepatitis C virus. J. Virol. 81, 629-638 (2007). (Pubitemid 46067890)
48. Berdichevsky, Y. et al. A novel high throughput screening assay for HCV NS3 serine protease inhibitors. J. Virol. Methods 107, 245-255 (2003). (Pubitemid 36005509)
49. Twining, S. S. Fluorescein isothiocyanate-labeled casein assay for proteaolytic enzymes. Anal. Biochem. 143, 30-34 (1984). (Pubitemid 15157534)
50. Bernstein, F. C. et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112, 535-542 (1977). (Pubitemid 8109216)
51. Feng, Z. et al. Ligand Depot: a data warehouse for ligands bound to macromolecules. Bioinformatics 20, 2153-2155 (2004). (Pubitemid 39236573)
52. Sobolev, V., Sorokine, A., Prilusky, J., Abola, E. E. & Edelman, M. Automated analysis of interatomic contacts in proteins. Bioinformatics 15, 327-332 (1999). (Pubitemid 29213759)
53. Porter, C. T., Bartlett, G. J. & Thornton, J. M. The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res. 32, D129-133 (2004). (Pubitemid 38081621)
54. Chen, C. Y. TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One 6, e15939 (2011).
55. Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785-2791 (2009).
56. The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrodinger, LLC.
57. Ciofani, G., Danti, S., D'Alessandro, D., Moscato, S. & Menciassi, A. Assessing cytotoxicity of boron nitride nanotubes: Interference with MTT assay. Biochem. Biophys. Res. Commun. 394, 405-411 (2010).
58. OECD Guidelines for the testing of chemicals. OECD 423. Acute Oral Toxicity-Acute toxic class method. Organization for Economic Cooperation and Development, Paris (2001).
59. OECD. (2006). Report of the Validation of the Updated Test Guideline 407: Repeat Dose 28-day Oral Toxicity Study in Laboratory Rats. SeriesonTesting and Assessment No 59, ENV/JM/MONO(2006)26.
60. Haid, S. et al. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology 143, 213-222 (2012).